News from hadasit bio-holdings ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 04, 2013, 08:30 ET

Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property...

Sep 11, 2013, 09:14 ET

KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.5M

 Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, based on intellectual property developed and...

Jun 05, 2013, 09:22 ET

Hadasit Bio-Holdings Ltd. to Present at the Third Annual Connecticut-Israel Technology Summit

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property...

May 23, 2013, 15:22 ET

Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed...

Apr 09, 2013, 09:00 ET

Hadasit Bio-Holdings CEO Letter to Shareholders

Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed...

Apr 04, 2013, 09:11 ET

Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property...

Feb 04, 2013, 08:30 ET

KAHR Medical Granted U.S. Patent Approval for One of its Lead Products in Development, KAHR-101

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed...

Jan 28, 2013, 09:00 ET

Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) and its portfolio companies ProtAb Ltd. ("ProtAb") and KAHR Medical Ltd. ("KAHR") announced...

Jan 22, 2013, 09:00 ET

Hadasit Bio-Holdings' Portfolio Companies Receive Funding to Support Clinical Trial Preparations and Obtain Regulatory Approvals in U.S. and Europe

Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed...

Nov 12, 2012, 09:00 ET

Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime Inc.

 Hadasit Bio-Holdings Ltd. (OTC: HADSY, TASE: HDST) a publicly traded portfolio of biotech companies, all based on intellectual...

Oct 24, 2012, 09:00 ET

Enlivex Therapeutics Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property...

Oct 16, 2012, 09:25 ET

Hadasit Bio-Holdings to Participate in Hadassah Centennial Convention

 Hadasit Bio-Holdings Ltd. (OTC: HADSY, TASE: HDST) a publicly traded portfolio of biotech companies, all based on intellectual property...

Jul 12, 2012, 15:30 ET

Hadasit Bio-Holdings Interviewed by Wall Street Reporter

 Hadasit Bio-Holdings Ltd. (OTC: HADSY, TASE: HDST) a publicly traded portfolio of biotech companies, all based on intellectual property...

Jun 18, 2012, 09:00 ET

KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million

 Hadasit Bio-Holdings ("HBL") (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, based on intellectual...

May 24, 2012, 09:10 ET

Thrombotech Ltd. to Merge with D-Pharm Ltd.

Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual property developed...

Apr 12, 2012, 09:00 ET

BioMarCare Technologies Ltd. and Ariadne Inc. Receive $900,000 Grant from the BIRD Foundation to Support Joint Collaboration

 Hadasit Bio-Holdings, Ltd. - (TASE: HDST; OTCBB: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property...

Mar 29, 2012, 11:27 ET

BioMarCare Receives Strategic Investment From Micromedic Ltd., a Subsidiary of BioLight Ltd.

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual...

Mar 12, 2012, 16:00 ET

Hadasit Bio-Holdings Ltd. Portfolio Companies - Thrombotech Ltd. and BioMarCare Technologies Ltd. to Receive Additional Government Grants

 Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) and its portfolio companies Thrombotech Ltd. ("Thrombotech") and BioMarCare Technologies...

Mar 05, 2012, 09:27 ET

Thrombotech Ltd. Receives Regulatory Approval for Phase IIa Trials in the U.S.

Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual property developed and...

Jan 23, 2012, 09:00 ET

Enlivex Completes Patient Enrollment in its Phase I/II Clinical Trial

Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual property developed...